SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/28/23 111, Inc. 20-F 12/31/22 109:13M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual or Annual-Transition Report by a Foreign HTML 3.82M Non-Canadian Issuer 2: EX-8.1 Opinion of Counsel re: Tax Matters HTML 34K 5: EX-13.1 Annual or Quarterly Report to Security Holders HTML 31K 6: EX-13.2 Annual or Quarterly Report to Security Holders HTML 31K 3: EX-12.1 Statement re: the Computation of Ratios HTML 34K 4: EX-12.2 Statement re: the Computation of Ratios HTML 35K 7: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 31K 8: EX-15.2 Letter re: Unaudited Interim Financial Info HTML 29K 9: EX-15.3 Letter re: Unaudited Interim Financial Info HTML 31K 10: EX-16.1 Letter re: a Change in Accountant HTML 36K 16: R1 Document and Entity Information HTML 111K 17: R2 Consolidated Balance Sheets HTML 159K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K 19: R4 Consolidated Statements of Comprehensive Loss HTML 135K 20: R5 Consolidated Statements of Comprehensive Loss HTML 32K (Parenthetical) 21: R6 Consolidated Statements of Changes in HTML 117K Shareholders' Equity (Deficit) 22: R7 Consolidated Statements of Cash Flows HTML 162K 23: R8 Organization and Principal Activities HTML 55K 24: R9 Summary of Principal Accounting Policies HTML 243K 25: R10 Short-Term Investments HTML 38K 26: R11 Notes Receivable HTML 32K 27: R12 Inventories HTML 37K 28: R13 Prepayments and Other Current Assets HTML 46K 29: R14 Leases HTML 52K 30: R15 Short-Term Borrowings HTML 37K 31: R16 Accrued Expenses and Other Current Liabilities HTML 53K 32: R17 Redeemable Non-Controlling Interests HTML 43K 33: R18 Non-Controlling Interests HTML 34K 34: R19 Ordinary Shares HTML 39K 35: R20 Net Revenues HTML 64K 36: R21 Share-Based Compensation HTML 155K 37: R22 Loss Per Share HTML 52K 38: R23 Income Tax Expense HTML 69K 39: R24 Mainland China Contribution Plan HTML 33K 40: R25 Restricted Net Assets HTML 33K 41: R26 Commitments and Contingencies HTML 33K 42: R27 Subsequent Events HTML 33K 43: R28 Additional Financial Information- Financial HTML 193K Statements Schedule I 44: R29 Summary of Principal Accounting Policies HTML 322K (Policies) 45: R30 Organization and Principal Activities (Tables) HTML 52K 46: R31 Summary of Principal Accounting Policies (Tables) HTML 157K 47: R32 Short-Term Investments (Tables) HTML 37K 48: R33 Inventories (Tables) HTML 38K 49: R34 Prepayments and Other Current Assets (Tables) HTML 46K 50: R35 Leases (Tables) HTML 50K 51: R36 Accrued Expenses and Other Current Liabilities HTML 52K (Tables) 52: R37 Redeemable Non-Controlling Interests (Tables) HTML 41K 53: R38 Net Revenues (Tables) HTML 61K 54: R39 Share-Based Compensation (Tables) HTML 148K 55: R40 Loss Per Share (Tables) HTML 52K 56: R41 Income Tax Expense (Tables) HTML 63K 57: R42 Organization and Principal Activities (Details) HTML 52K 58: R43 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Basis HTML 40K of presentation (Details) 59: R44 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Basis HTML 66K of consolidation (Details) 60: R45 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 129K Balances of the VIEs and Short-term investments (Details) 61: R46 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 37K Accounts receivable net (Details) 62: R47 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 50K Property and equipment (Details) 63: R48 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 41K Intangible assets and Impairment of long-lived assets (Details) 64: R49 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Product HTML 42K revenues and Service revenues (Details) 65: R50 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Selling HTML 44K and marketing expenses and Others (Details) 66: R51 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 35K Concentration of credit risk (Details) 67: R52 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Fair HTML 46K value (Details) 68: R53 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 37K Treasury shares (Details) 69: R54 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Product HTML 67K revenues and segment profit (Loss) (Details) 70: R55 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 65K Reconciliation of reportable segment revenues (Details) 71: R56 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 53K Revenues from different product groups and services (Details) 72: R57 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - Leases HTML 35K and Convenience translation (Details) 73: R58 SUMMARY OF PRINCIPAL ACCOUNTING POLICIES - HTML 51K Structured payment arrangement (Details) 74: R59 Short-Term Investments (Details) HTML 43K 75: R60 Notes Receivable (Details) HTML 40K 76: R61 Inventories (Details) HTML 34K 77: R62 Prepayments and Other Current Assets (Details) HTML 48K 78: R63 Leases (Details) HTML 74K 79: R64 Short-Term Borrowings (Details) HTML 117K 80: R65 Accrued Expenses and Other Current Liabilities HTML 57K (Details) 81: R66 Redeemable Non-Controlling Interests (Details) HTML 58K 82: R67 Non-Controlling Interests (Details) HTML 55K 83: R68 Ordinary Shares (Details) HTML 73K 84: R69 NET REVENUES - Disaggregation of revenues HTML 49K (Details) 85: R70 NET REVENUES - Contract balance (Details) HTML 48K 86: R71 NET REVENUES - Additional information (Details) HTML 36K 87: R72 Share-Based Compensation (Details) HTML 73K 88: R73 Share-Based Compensation - Non-Employee Share HTML 67K Options (Details) 89: R74 SHARE-BASED COMPENSATION - Assumptions used to HTML 53K estimate the fair values of the share options granted (Details) 90: R75 SHARE-BASED COMPENSATION - Employee and HTML 104K Non-Employee Share Options Activity (Details) 91: R76 SHARE-BASED COMPENSATION - Restricted Share Units HTML 97K and Employee ownership plan (Details) 92: R77 SHARE-BASED COMPENSATION - Employee ownership plan HTML 67K of Yaofang (Details) 93: R78 SHARE-BASED COMPENSATION - Share-based HTML 39K compensation for all share options and restricted share units (Details) 94: R79 LOSS PER SHARE - Computation of basic and diluted HTML 54K loss per share (Details) 95: R80 LOSS PER SHARE - Share options and restricted HTML 34K share units outstanding excluded from calculation of diluted loss per share (Details) 96: R81 Income Tax Expense (Details) HTML 56K 97: R82 Income Tax Expense - Principal components of HTML 53K deferred income tax assets and liabilities (Details) 98: R83 Mainland China Contribution Plan (Details) HTML 31K 99: R84 Restricted Net Assets (Details) HTML 37K 100: R85 Subsequent Events (Details) HTML 34K 101: R86 Additional Financial Information - Financial HTML 110K Statements Schedule I - Balance Sheets (Details) 102: R87 Additional Financial Information - Financial HTML 76K Statements Schedule I - Statements of Comprehensive Loss (Details) 103: R88 Additional Financial Information - Financial HTML 32K Statements Schedule I - Statements of Comprehensive Loss - Additional Information (Details) 104: R89 Additional Financial Information - Financial HTML 92K Statements Schedule I - Statements of Cash Flows (Details) 107: XML IDEA XML File -- Filing Summary XML 200K 105: XML XBRL Instance -- yi-20221231x20f_htm XML 2.80M 106: EXCEL IDEA Workbook of Financial Reports XLSX 221K 13: EX-101.CAL XBRL Calculations -- yi-20221231_cal XML 228K 14: EX-101.DEF XBRL Definitions -- yi-20221231_def XML 969K 15: EX-101.LAB XBRL Labels -- yi-20221231_lab XML 1.79M 11: EX-101.PRE XBRL Presentations -- yi-20221231_pre XML 1.45M 12: EX-101.SCH XBRL Schema -- yi-20221231 XSD 247K 108: JSON XBRL Instance as JSON Data -- MetaLinks 537± 872K 109: ZIP XBRL Zipped Folder -- 0001104659-23-051944-xbrl Zip 990K
Exhibit 8.1
List of Significant Subsidiaries of the Registrant
Name of Subsidiary |
| Jurisdiction |
| | |
Yao Wang Corporation Limited | | Hong Kong |
| | |
1 Pharmacy Technology (Shanghai) Co., Ltd. | | PRC |
| | |
Guangdong Yihao Pharmacy Co., Ltd. | | PRC |
| | |
Guangdong Yihao Pharmaceutical Chain Co., Ltd. | | PRC |
| | |
Wuhan Central China Drug Trading Co., Ltd. | | PRC |
| | |
Chongqing Yihao Pharmacy Co., Ltd. | | PRC |
| | |
Tianjin Yihao Pharmacy Co., Ltd. | | PRC |
| | |
Kunshan Yifang Pharmacy Co., Ltd. | | PRC |
| | |
Hubei Yihao Pharmacy Co., Ltd. | | PRC |
| | |
Shanxi Yaofang Pharmacy Co., Ltd. | | PRC |
| | |
Liaoning Yaofang Pharmacy Co., Ltd. | | PRC |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/23 SEC UPLOAD¶ 9/12/23 2:39K 111, Inc. 7/21/23 SEC UPLOAD¶ 9/12/23 2:47K 111, Inc. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/21 111, Inc. 20-F 12/31/20 119:15M Toppan Merrill/FA 4/16/20 111, Inc. 20-F 12/31/19 116:12M Toppan Merrill/FA 1/22/19 111, Inc. S-8 1/22/19 4:593K Toppan Merrill/FA 8/29/18 111, Inc. F-1/A 13:5.9M Toppan Merrill-FA 8/15/18 111, Inc. F-1 26:7.9M Toppan Merrill-FA |